Mayo Clinic's Q4 2023 13F: 2 new positions, 4 exits

Form 13F-HR for the quarter ended Dec 31, 2023 · filed Feb 13, 2024 · 7 reported positions · accession 0000950123-24-001748

What changed this quarter

Mayo Clinic's changes in reported equity positions, Q4 2023
Activity Security Weight before Weight now Change Shares Shares %
Reduced MSCI ACWI ETF (ACWI) 85.2% 71.5% −13.7 pts −365K sh −76%
New Immunome Inc Com (IMNM) — 7.2% +7.2 pts +108K sh new
Exited BLACK STONE MINERALS (BSM) 5.5% — −5.5 pts −166K sh −100%
Exited Miromatrix Med Inc (MIRO) 0.5% — −0.5 pts −192K sh −100%
Exited Clearpoint Neuro Inc (CLPT) 0.4% — −0.4 pts −38,114 sh −100%
Exited EVELO BIOSCIENCES INC (EVLO) 0.2% — −0.2 pts −22,577 sh −100%
New ImmunityBio Inc Com (IBRX) — 0.0% 0.0 pts +1,403 sh new

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 100.0% of the equity book

Changes in the top 10 this quarter: IMNM entered · IBRX entered · BSM left · MIRO left · CLPT left · EVLO left

# Security Weight before Weight now
1 MSCI ACWI ETF (ACWI) 85.2% 71.5%
2 Zentalis Pharmaceuticals Inc (ZNTL) 7.2% 17.5%
3 Immunome Inc Com (IMNM) 0.0% 7.2% Entered the top 10
4 Neuroone Medical Technologies (NMTC) 0.3% 1.8%
5 UNITY BIOTECHNOLOGY INC (UNBX) 0.6% 1.5%
6 Scilex Holding Co (SCLX) 0.1% 0.5%
7 ImmunityBio Inc Com (IBRX) 0.0% 0.0% Entered the top 10
— BLACK STONE MINERALS (BSM) 5.5% 0.0% Left the top 10
— Miromatrix Med Inc (MIRO) 0.5% 0.0% Left the top 10
— Clearpoint Neuro Inc (CLPT) 0.4% 0.0% Left the top 10
— EVELO BIOSCIENCES INC (EVLO) 0.2% 0.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).